PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PBX3
hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-29
DOI
10.1002/cam4.2321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer
- (2018) Sebastian Lamprecht et al. CLINICAL CANCER RESEARCH
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Impact of confounding by leukocyte composition on associations of leukocyte DNA methylation with common risk factors
- (2017) Jonathan Alexander Heiss et al. Epigenomics
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
- (2015) Yoshinaga Okugawa et al. GASTROENTEROLOGY
- The Propensity Score
- (2015) Jason S. Haukoos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer
- (2014) Zuo-Ming Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
- (2014) Muriel X.G. Draht et al. Molecular Oncology
- Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates
- (2013) E. Longobardi et al. DEVELOPMENTAL DYNAMICS
- KRASmutations andCDKN2Apromoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer
- (2013) Maija R. J. Kohonen-Corish et al. INTERNATIONAL JOURNAL OF CANCER
- PBX3 is overexpressed in gastric cancer and regulates cell proliferation
- (2013) Yanke Li et al. TUMOR BIOLOGY
- Clinical Outcomes of Patients with Microsatellite-Unstable Colorectal Carcinomas Depend on L1 Methylation Level
- (2012) Ye-Young Rhee et al. ANNALS OF SURGICAL ONCOLOGY
- Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML
- (2012) Z. Li et al. BLOOD
- PBX3 is an important cofactor of HOXA9 in leukemogenesis
- (2012) Z. Li et al. BLOOD
- Prognostic role of methylated free circulating DNA in colorectal cancer
- (2012) Alexander B. Philipp et al. INTERNATIONAL JOURNAL OF CANCER
- DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients
- (2012) TORBJÖRN K. NILSSON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing
- (2012) Michel P Bihl et al. Journal of Translational Medicine
- A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer
- (2012) Marina Antelo et al. PLoS One
- KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer
- (2012) Patricia Moya et al. TUMOR BIOLOGY
- Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer
- (2011) Joo Mi Yi et al. CLINICAL CANCER RESEARCH
- DNA Methylation Array Analysis Identifies Profiles of Blood-Derived DNA Methylation Associated With Bladder Cancer
- (2011) Carmen J. Marsit et al. JOURNAL OF CLINICAL ONCOLOGY
- Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer
- (2011) Hai-Bo Han et al. JOURNAL OF PATHOLOGY
- Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
- (2011) Håkon Ramberg et al. Molecular Cancer
- Implementing prognostic and predictive biomarkers in CRC clinical trials
- (2011) Sandra Van Schaeybroeck et al. Nature Reviews Clinical Oncology
- Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls
- (2011) Katrina S. Pedersen et al. PLoS One
- Targeting HOX and PBX transcription factors in ovarian cancer
- (2010) Richard Morgan et al. BMC CANCER
- DNA methylation predicts recurrence from resected stage III proximal colon cancer
- (2010) Joong Bae Ahn et al. CANCER
- Hypomethylation of the IGF2 DMR in Colorectal Tumors, Detected by Bisulfite Pyrosequencing, Is Associated With Poor Prognosis
- (2010) Yoshifumi Baba et al. GASTROENTEROLOGY
- Molecular Detection of Colorectal Neoplasia
- (2010) David A. Ahlquist GASTROENTEROLOGY
- Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
- (2010) Thomas E. Liggett et al. GYNECOLOGIC ONCOLOGY
- Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients
- (2010) Thomas E. Liggett et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review
- (2010) Kaori Shima et al. INTERNATIONAL JOURNAL OF CANCER
- Methylation Markers for Small Cell Lung Cancer in Peripheral Blood Leukocyte DNA
- (2010) Liang Wang et al. Journal of Thoracic Oncology
- Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence
- (2009) Andreas Herbst et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Aberrant p16INK4a methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity
- (2009) Hiroyuki Mitomi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer
- (2009) Andrew E. Teschendorff et al. PLoS One
- Inhibition of cancer cell proliferation by designed peptide amphiphiles
- (2008) Lorenzo Aulisa et al. Acta Biomaterialia
- Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
- (2008) L. Barault et al. CANCER RESEARCH
- A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer
- (2008) Shuji Ogino et al. JNCI-Journal of the National Cancer Institute
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study
- (2008) Martin Widschwendter et al. PLoS One
- PBX proteins: much more than Hox cofactors
- (2007) Audrey Laurent et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started